• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

lung cancer

oncology cancer test mammogram mammography breast cancer
Pharma

AZ, Daiichi's Datroway scores overall survival win in TNBC

Datroway has become the first drug to show an overall survival benefit against chemotherapy for certain patients with triple-negative breast cancer.
Kevin Dunleavy Oct 6, 2025 10:48am
Sketch of lungs

Guardant backs ALA's lung cancer testing awareness drive

Sep 25, 2025 9:45am
Graphic of a fork in the road with arrows pointing in either direction

Editor's Corner—Summit must submit to Big Pharma, stat

Sep 10, 2025 2:50pm
Summit

Summit's global PD-1xVEGF data show new promising OS trend

Sep 7, 2025 3:30am
Boehringer Ingelheim

Boehringer's lung cancer med passes muster with the FDA

Aug 8, 2025 3:52pm
Johnson  Johnson 3rd opinion lung cancer campaign

J&J coins the term '3rd opinion' to empower lung cancer patients

Aug 1, 2025 10:38am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings